Voloridge Investment Management, LLC Seagen Inc. Transaction History

Voloridge Investment Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$191.51 - $216.16 $14.6 Million - $16.5 Million	76,450 Added 12.05%	710,794 $151 Million
Q2 2023 Aug 14, 2023	BUY	$187.64 - $206.25 $96.1 Million - $106 Million	512,371 Added 420.07%	634,344 $122 Million
Q1 2023 May 15, 2023	BUY	$127.59 - $203.08 $15.6 Million - $24.8 Million	121,973 New	121,973 $24.7 Million
Q3 2021 Nov 15, 2021	SELL	$142.45 - $169.82 $4.67 Million - $5.57 Million	-32,777 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$135.08 - $161.1 $34.4 Million - $41.1 Million	-255,027 Reduced 88.61%	32,777 $5.18 Million

Q1 2021 May 17, 2021	BUY	$137.51 - $190.8 $39.6 Million - $54.9 Million	287,804 New	287,804 $40 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.